The -174G/C Interleukin-6 Gene Promoter Polymorphism as a Genetic Marker of Differences in Therapeutic Response to Methotrexate and Leflunomide in Rheumatoid Arthritis.
Ruiz-Padilla AJ, Gamez-Nava JI, Saldaña-Cruz AM, Murillo-Vazquez JD, Vazquez-Villegas ML, Zavaleta-Muñiz SA, Martín-Márquez BT, Ponce-Guarneros JM, Rodriguez Jimenez NA, Flores-Chavez A, Sandoval-Garcia F, Vasquez-Jimenez JC, Cardona-Muñoz EG, Totsuka-Sutto SE, Gonzalez-Lopez L.
Ruiz-Padilla AJ, et al.
Biomed Res Int. 2016;2016:4193538. doi: 10.1155/2016/4193538. Epub 2016 Sep 21.
Biomed Res Int. 2016.
PMID: 27738630
Free PMC article.